Clinical value of high-risk HPV nucleic acid detection kit careHPV in screening of cervical cancer and precancerous lesions

Jing FANG,Ying HONG
DOI: https://doi.org/10.3969/j.issn.1673-5293.2016.04.014
2016-01-01
Abstract:Objective To assess the clinical value of careHPV test in screening of cervical cancer and precancerous lesions.Methods From 2010 to 2012 cervical specimens were collected from women aged 30-59 years old visiting department of gynecology of Nanjing Drum Tower Hospital between.They were detected by careHPV test, HC2, HPV-PCR test and TCT.Women with TCT≥ASC-US had colposcopy with directed biopsy and endocervical curettage if necessary.Based on the gold standard of histopathology, patients with CIN2 or higher belonged to high-risk group and those with inflammation/CIN1 belonged to benign group.Results Totally 404 valid samples were collected. There were 42 cases in high-risk group, 50 cases in benign group, and 312 cases in normal group.The value of Kappa was 0.833 in indicating the consistency of detection results between careHPV test and HC2 (P<0.0001) and the concordance rate was 93.81%.The value of Kappa was 0.707 in indicating the consistency of detection results between careHPV test and HPV-PCR (P<0.0001) and the concordance rate was 88.12%.The sensitivity and specificity of careHPV test in detecting lesions≥CIN 2 were 85.71% and 83.15%, respectively.Conclusion The careHPV test is highly consistent with HC2 and HPV-PCR test.CareHPV has good sensitivity and specificity in the detection of HPV infection with short time consuming, and is expected to be the main method for screening of cervical cancer and precancerous lesions in the areas with relatively insufficient medical resources.
What problem does this paper attempt to address?